Lista de obras - Dmitri Pchejetski - Dominio Público Uruguay

A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

artículo científico publicado en 2011

Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.

artículo científico publicado en 2011

Apoptosis in serum-deprived vascular smooth muscle cells: evidence for cell volume-independent mechanism.

artículo científico publicado en 2004

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report

artículo científico publicado en 2020

Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.

artículo científico publicado en 2008

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups

artículo científico publicado en 2021

Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer.

artículo científico publicado en 2010

Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage.

artículo científico publicado en 2012

Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation.

artículo científico publicado en 2013

FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.

artículo científico publicado en 2010

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors

scientific article published on 24 July 2018

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer

artículo científico publicado en 2016

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.

artículo científico publicado en 2010

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway

artículo científico publicado en 2014

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma

artículo científico publicado en 2015

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.

artículo científico publicado en 2017

Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis

scientific journal article

Purinergic-induced signaling in C11-MDCK cells inhibits the secretory Na-K-Cl cotransporter.

artículo científico publicado en 2003

Serum molecular signatures of weight change during early breast cancer chemotherapy.

artículo científico publicado en 2009

Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.

artículo científico publicado en 2014

Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.

artículo científico publicado en 2009

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer

artículo científico publicado en 2014

TGFβ1–Endo180‐dependent collagen deposition is dysregulated at the tumour–stromal interface in bone metastasis ⬇️

artículo científico publicado el 8 de diciembre de 2011

The emerging role of FTY720 (Fingolimod) in cancer treatment

artículo científico publicado en 2016

The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1α protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6

artículo científico publicado en 2010

Therapeutic Potential of Targeting SK1 in Human Cancers

artículo científico publicado el 1 de enero de 2013

Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer ⬇️

artículo científico publicado el 13 de septiembre de 2011

Lista de obras de Dmitri Pchejetski

A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy

Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.

Apoptosis in serum-deprived vascular smooth muscle cells: evidence for cell volume-independent mechanism.

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report

Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models.

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups

Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer.

Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage.

Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation.

FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study.

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.

Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis

Purinergic-induced signaling in C11-MDCK cells inhibits the secretory Na-K-Cl cotransporter.

Serum molecular signatures of weight change during early breast cancer chemotherapy.

Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.

Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer

TGFβ1–Endo180‐dependent collagen deposition is dysregulated at the tumour–stromal interface in bone metastasis ⬇️

The emerging role of FTY720 (Fingolimod) in cancer treatment

The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1α protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6

Therapeutic Potential of Targeting SK1 in Human Cancers

Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer ⬇️